| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aca804053b71df436b75a3157a9bf737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f98e3c36ba039b09e4fdb0f529994a9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60cabc4ce80d392076a1eaf2a970a548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc38c2c3d52d7562d7641221d5ac727d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f87c52a9beab6b1023d2f5ea9b33f877 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f39cc0f9bb186a471be99a7c4c2b9c37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb3abef53c82948f0799e132639d9e6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70c520e7db034300a07dd1e5114ea41b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d3fc28f0f4c046ac8b6088feea16f30 |
| publicationDate |
2017-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9629895-B2 |
| titleOfInvention |
Method for prevention or treatment of intractable inflammatory bowel disease |
| abstract |
An object of the present invention is to provide methods for preventing or treating a steroid-resistant or steroid-dependent inflammatory bowel disease. The object can be achieved by a method for preventing or treating a steroid-resistant or steroid-dependent inflammatory bowel disease in a patient in need of the prevention or treatment of the inflammatory bowel disease, comprises administering an effective amount of adrenomedullin, a modified product thereof having an activity of suppressing steroid-resistant or steroid-dependent inflammation, or a salt thereof having an activity of suppressing steroid-resistant or steroid-dependent inflammation, to the patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10335455-B2 |
| priorityDate |
2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |